Sign in
Home
About Us
Contact Us
Privacy Policy
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Privacy Policy
Password recovery
Recover your password
your email
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Australian Biotech Company News
Home
About Us
Contact Us
Privacy Policy
Home
Tags
Blood disorders
Tag: Blood disorders
Biotechnology
Current and Future CEOs See Opportunities in Editas’ Challenges
BioChannel
-
April 26, 2022
Biotechnology
StockWatch: Kaleido Shares Crater as Company Ceases Operations
BioChannel
-
April 8, 2022
Biotechnology
StockWatch: ALS Setback Hammers Amylyx, Longeveron Doubles on Positive Alzheimer’s Data
BioChannel
-
April 1, 2022
Biotechnology
Bleeding Cut: CSL Behring Plans H1 Filings for Hemophilia B Gene...
BioChannel
-
March 8, 2022
Biotechnology
Global Blood Therapeutics CEO Defends Price of Sickle-Cell Drug Oxbryta
BioChannel
-
February 13, 2020
Biotechnology
Gene Therapy Trial Helps Six X-CGD Patients
BioChannel
-
January 28, 2020
Biotechnology
Senescent Cells Promote Blood Clotting
BioChannel
-
September 26, 2019
Recent posts
NADIM II trial provides further support for neoadjuvant chemoimmunotherapy for patients with resectable non-small...
BioChannel
-
August 8, 2022
Genmab and BioNTech expand collaboration to develop and commercialize immunotherapy candidates
BioChannel
-
August 8, 2022
Apriori Bio’s AI Platform Provides Variant-Proof Protection from Viral Threats
BioChannel
-
August 8, 2022
Random article
NADIM II trial provides further support for neoadjuvant chemoimmunotherapy for patients...
Genmab and BioNTech expand collaboration to develop and commercialize immunotherapy candidates
Apriori Bio’s AI Platform Provides Variant-Proof Protection from Viral Threats
Lithuanian biotech group develops closer ties with Korea’s biotech industry –...
